Yan Jia

4.7k total citations
89 papers, 1.8k citations indexed

About

Yan Jia is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yan Jia has authored 89 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 24 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in Yan Jia's work include RNA modifications and cancer (11 papers), Epigenetics and DNA Methylation (11 papers) and Cancer-related gene regulation (10 papers). Yan Jia is often cited by papers focused on RNA modifications and cancer (11 papers), Epigenetics and DNA Methylation (11 papers) and Cancer-related gene regulation (10 papers). Yan Jia collaborates with scholars based in China, United States and United Kingdom. Yan Jia's co-authors include Mingzhou Guo, James G. Herman, Yunsheng Yang, Peter B. Bitterman, Carston R. Wagner, Vitaly A. Polunovsky, Malcolm V. Brock, Jianping Lu, Yuwei Xia and Fu Shen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yan Jia

86 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Jia China 25 1.0k 405 354 242 226 89 1.8k
Yu Sun China 20 456 0.4× 553 1.4× 311 0.9× 159 0.7× 380 1.7× 93 1.5k
Hongcheng Zhu China 27 929 0.9× 527 1.3× 586 1.7× 128 0.5× 431 1.9× 97 1.9k
Qinglian Wen China 24 755 0.7× 534 1.3× 423 1.2× 120 0.5× 275 1.2× 67 1.6k
Qiong Zou China 22 786 0.8× 349 0.9× 397 1.1× 80 0.3× 235 1.0× 105 1.4k
Takeshi Tamaki Japan 23 453 0.4× 326 0.8× 287 0.8× 159 0.7× 224 1.0× 94 1.8k
Hiroshi Tsushima Japan 19 691 0.7× 399 1.0× 204 0.6× 139 0.6× 95 0.4× 50 1.6k
Helong Zhang China 26 909 0.9× 636 1.6× 535 1.5× 76 0.3× 477 2.1× 132 2.0k
Yi Huang China 22 838 0.8× 275 0.7× 399 1.1× 89 0.4× 203 0.9× 83 1.4k
Ping Ji China 21 1.1k 1.1× 253 0.6× 651 1.8× 105 0.4× 132 0.6× 67 1.6k

Countries citing papers authored by Yan Jia

Since Specialization
Citations

This map shows the geographic impact of Yan Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Jia more than expected).

Fields of papers citing papers by Yan Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Jia. The network helps show where Yan Jia may publish in the future.

Co-authorship network of co-authors of Yan Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Jia. A scholar is included among the top collaborators of Yan Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Jia. Yan Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yun, Xiaojing Liu, Linglin Zhang, et al.. (2025). The 5-Aminolevulinic Acid Photodynamic Therapy Modulates Lipid Production by Protein Kinase B/JunD-Mediated NR4A1 Activation in the Treatment of Acne Vulgaris. Journal of Investigative Dermatology. 145(9). 2179–2190.e2. 2 indexed citations
2.
Wang, Xiaorui, et al.. (2024). Circ_0084653 promotes the tumor progression and immune escape in triple-negative breast cancer via the deubiquitination of MYC and upregulation of SOX5. International Journal of Biological Macromolecules. 280(Pt 1). 135655–135655. 1 indexed citations
3.
Vorperian, Sevahn K., Brian C. DeFelice, Yan Jia, et al.. (2024). Deconvolution of Human Urine across the Transcriptome and Metabolome. Clinical Chemistry. 70(11). 1344–1354. 5 indexed citations
4.
Li, Xiang, et al.. (2024). Knockdown of liver cancer cell‐secreted exosomal PSMA5 controls macrophage polarization to restrain cancer progression by blocking JAK2/STAT3 signaling. Immunity Inflammation and Disease. 12(2). e1146–e1146. 10 indexed citations
5.
Lin, Jing, et al.. (2023). SPATS2 is correlated with cell cycle progression and immune cells infiltration in hepatocellular carcinoma. BMC Gastroenterology. 23(1). 8–8. 1 indexed citations
6.
Liu, Yanfeng, Yi Liu, Xuefeng Chen, & Yan Jia. (2023). Clinical characteristics and mortality risk factors of mixed bacterial infections in hematopoietic stem cell transplantation recipients. Frontiers in Cellular and Infection Microbiology. 13. 1223824–1223824.
7.
8.
Wang, Chunqing, Xiaoqing Zhao, Yunqiu Wang, et al.. (2023). PKCζ phosphorylates VASP to mediate chemotaxis in breast cancer cells. Experimental Cell Research. 433(2). 113823–113823. 1 indexed citations
9.
Qiao, Kailiang, Jingxia Han, Haohao Zhang, et al.. (2023). Intratumor Mycoplasma promotes the initiation and progression of hepatocellular carcinoma. Cell Reports. 42(12). 113563–113563. 5 indexed citations
10.
Yu, Tao, Yan Jia, Xue Zhang, et al.. (2022). RNA N6-methyladenosine modification mediates downregulation of NR4A1 to facilitate malignancy of cervical cancer. Cell & Bioscience. 12(1). 207–207. 11 indexed citations
11.
Wang, Jing, Chao Qiu, Yanling Jin, et al.. (2022). Feasibility of iNKT cell and PD-1+CD8+ T cell-based immunotherapy in patients with lung adenocarcinoma: Preliminary results of a phase I/II clinical trial. Clinical Immunology. 238. 108992–108992. 14 indexed citations
12.
Zhao, Weipeng, Linlin Sun, Xichuan Li, et al.. (2021). SCD5 expression correlates with prognosis and response to neoadjuvant chemotherapy in breast cancer. Scientific Reports. 11(1). 8976–8976. 14 indexed citations
13.
Cai, Shijiao, Yunpeng Bai, Huan Wang, et al.. (2020). Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin. Journal of Experimental & Clinical Cancer Research. 39(1). 135–135. 25 indexed citations
14.
Gao, Meng, Juan An, Xin Wang, et al.. (2020). <p>Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer</p>. OncoTargets and Therapy. Volume 13. 8475–8493. 10 indexed citations
15.
Wang, Huiwen, Tianming Zhao, Wei Liu, et al.. (2020). A Novel miRNA Restores the Chemosensitivity of AML Cells Through Targeting FosB. Frontiers in Medicine. 7. 582923–582923. 8 indexed citations
16.
Ma, Xiaolu, Shuai Li, Zhihui Li, et al.. (2020). MRI-Based Radiomics of Rectal Cancer: Assessment of the Local Recurrence at the Site of Anastomosis. Academic Radiology. 28. S87–S94. 24 indexed citations
17.
Blay, Jean‐Yves, Patrick Schöffski, Sebastian Bauer, et al.. (2019). Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study. British Journal of Cancer. 120(11). 1026–1032. 31 indexed citations
18.
Nie, Pei, Guangjie Yang, Zhenguang Wang, et al.. (2019). A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma. European Radiology. 30(2). 1274–1284. 81 indexed citations
19.
Jia, Yan & Mingzhou Guo. (2011). Epigenetic changes in colorectal cancer. Chinese Journal of Cancer. 32(1). 21–30. 52 indexed citations
20.
Ghosh, Phalguni, Tsui‐Fen Chou, Yan Jia, et al.. (2008). Expression, purification and characterization of recombinant mouse translation initiation factor eIF4E as a dihydrofolate reductase (DHFR) fusion protein. Protein Expression and Purification. 60(2). 132–139. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026